Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Control Bionics Ltd. ( (AU:CBL) ) has shared an announcement.
Control Bionics Ltd. has announced the quotation of 8,852,473 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 17, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s market presence and providing additional capital to support its operations and growth strategies.
More about Control Bionics Ltd.
Control Bionics Ltd. operates in the biotechnology industry, focusing on developing and providing assistive technology solutions. The company specializes in creating products that enable individuals with disabilities to communicate and interact with their environment, emphasizing market segments that require advanced communication aids.
Average Trading Volume: 137,709
Technical Sentiment Signal: Sell
Current Market Cap: A$12.02M
For an in-depth examination of CBL stock, go to TipRanks’ Overview page.